focal adhesionprotein-tyrosine in response · 2005. 5. 16. · reminiscent of focal adhesions,...

5
Proc. Nati. Acad. Sci. USA Vol. 89, pp. 8487-8491, September 1992 Cell Biology Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin (signal transduction/exbraceflular matrix/integrins/polymerase chain reaction) STEVEN K. HANKS*, MIHAIL B. CALALB, MELINDA C. HARPER, AND SHEETAL K. PATEL Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232 Communicated by Stanley Cohen, June 1, 1992 ABSTRACT A homology-based cDNA cloning approach was used to identify a widely expressed protein-tyrosine kinase designated as "focal adhesion kinase" (FadK). The entire mouse FadK amino acid sequence was deduced from cDNA clones, revealing a large (119-kDa) non-membrane-sp protein-tyrosine kinase that lacks Src-homology SH2 and SH3 domains. Immunosaining of BALB/c 3T3 fibroblasts revealed that FadK is concentrated in focal adhesions. FadK is phos- phorylated on tyrosine in growing cultures of BALB/c 3T3 cells but contains little or no phosphotyrosine in cells detached by trypsinization. The tyrosine-phosphorylated state is re- gained within minutes when the cells are replated onto fibro- nectin. Activation of FadK may be an important early step in intracellular signal transduction pathways triggered in re- sponse to cell interactions with the extracellular matrix. The metazoan protein-tyrosine kinases (PTKs) make up a large segment of the eukaryotic protein kinase superfamily (1, 2) and are known for their oncogenic potential as well as their roles in regulating aspects of normal development (reviewed in refs. 3-5). PTKs are grouped into two broad structural classes on the basis of whether or not they span the plasma membrane. Membrane-spanning PTKs include receptors for various peptide growth and differentiation factors such as epidermal growth factor and platelet-derived growth factor. Receptor PTK activity is stimulated upon ligand binding, and subsequent receptor autophosphorylation followed by phos- phorylation of exogenous substrates is an initial event in the signal transduction pathway (reviewed in refs. 5 and 6). PTKs that do not span the plasma membrane (i.e., members of the Src subfamily) have also been implicated in the transduction of extracellular signals that control cell growth and differen- tiation (reviewed in refs. 7-9). Given what is known about the widespread involvement of PTKs in regulating developmental processes, we sought to identify and characterize PTKs, with the ultimate goal of obtaining insight into how cells respond to environmental cues that influence their growth and differentiation. In this report, we describe a non-membrane-spanning PTK identi- fied by a homology-based cDNA cloning strategy and present evidence that its activation may be part of a signal transduc- tion pathway triggered in response to cellular interactions with components of the extracellular matrix (ECM).t MATERIALS AND METHODS Amplification of PTK Catalytic-Domain cDNA Fragments by PCR. PTK cDNAs were amplified from adult rat testis poly(A)+ RNA by reverse transcriptase-directed PCR (10). PCR primers were designed to recognize conserved regions in PTK catalytic domains [upstream "HRDLAA" primers, 5'-CA(C/T)-(A/C)GN-GA(C/T)-(C/T)TN-GCN-GC-3'; downstream "DVWS(FY)G" primers, 5' -CC-(A/G)(A/T)A- N(C/G)(A/T)-CCA-NAC-(A/G)TC-3'; where N = (A/C/G/ T)]. The thermocycling parameters used were as follows: annealing, 2 min at 500C; extension, 3 min at 720C; denatur- ation, 0.5 min at 94TC. Amplified cDNA products of =210 base pairs were subcloned and nucleotide sequences were determined for 200 inserts picked at random. Isolation of cDNA Clones Encoding Mouse FadK and North- ern Analysis of Expression. The PCR product TK3 was used as a probe to screen (10) a mouse 8.5-day embryo cDNA library (11) constructed in AgtlO. To obtain clones represen- tative of the entire -4.5-kilobase (kb) transcript, it was necessary to rescreen the library with probes derived from the 5' and 3' ends of the initial cDNA isolates. Nucleotide sequences were determined, from both complementary strands, for four overlapping clones to obtain the composite sequence shown. RNA isolation and Northern hybridization were done as described (12). The blots were hybridized with a probe derived from a BamHI-Acc I fragment (nucleotides 3476- 4084) in the 3' untranslated region of the FadK cDNA. Production of Antiserum to FadK and Antibody Affinity Purification. Anti-FadK antiserum was obtained from New Zealand White rabbits immunized with a bacterially ex- pressed fusion protein consisting of the C-terminal 150 amino acid residues of mouse FadK, lying downstream of 16 vector- derived residues from the pT7-7 plasmid vector (13). Anti- bodies from the immune serum were affinity-purified (14) against the fusion protein blotted to Immobilon membrane (Millipore). Immunoprecipitation of FadK, Immune-Complex Kinase Assay, and Phospho Amino Acid Analysis. BALB/c 3T3 mouse fibroblasts (from W. J. Pledger, Vanderbilt Univer- sity) were maintained in Dulbecco's modified Eagle's me- dium (DMEM) supplemented with 10%o calf serum. Cellular proteins were metabolically labeled with [35S]methionine/ cysteine by incubating the cells for 16 hr at 37°C in methio- nine-free DMEM containing 5% complete DMEM, 4% calf serum, and Tran35S-label (1000 Ci/mmol; ICN; 1 Ci = 37 GBq) at 100 ,Ci/ml. Phosphoproteins were labeled by incu- bating the cells for 4 hr at 37°C in phosphate-free medium containing 4% calf serum and [32P]orthophosphate (9000 Ci/mmol; NEN) at 1.5 mCi/ml. Cells were lysed in RIPA buffer (50 mM Tris Cl, pH 7.4/150 mM NaCl/5 mM EDTA/1% Nonidet P-40/1% sodium deoxycholate/0.1% SDS/1% aprotinin, 50 mM NaF/0.1 mM Na3VO4) and im- munoprecipitation of FadK was achieved by mixing 2 ,u of antiserum with 1 ml of clarified lysate, incubating on ice for 1.5 hr, and then adding 50 ul of a 50% slurry of protein Abbreviations: ECM, extracellular matrix; PTK, protein-tyrosine kinase. *To whom reprint requests should be addressed. tIThe sequence reported in this paper has been deposited in the GenBank data base (accession no. M95408). 8487 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Downloaded by guest on May 31, 2021

Upload: others

Post on 25-Jan-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

  • Proc. Nati. Acad. Sci. USAVol. 89, pp. 8487-8491, September 1992Cell Biology

    Focal adhesion protein-tyrosine kinase phosphorylated in responseto cell attachment to fibronectin

    (signal transduction/exbraceflular matrix/integrins/polymerase chain reaction)

    STEVEN K. HANKS*, MIHAIL B. CALALB, MELINDA C. HARPER, AND SHEETAL K. PATELDepartment of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232

    Communicated by Stanley Cohen, June 1, 1992

    ABSTRACT A homology-based cDNA cloning approachwas used to identify a widely expressed protein-tyrosine kinasedesignated as "focal adhesion kinase" (FadK). The entiremouse FadK amino acid sequence was deduced from cDNAclones, revealing a large (119-kDa) non-membrane-spprotein-tyrosine kinase that lacks Src-homology SH2 and SH3domains. Immunosaining ofBALB/c 3T3 fibroblasts revealedthat FadK is concentrated in focal adhesions. FadK is phos-phorylated on tyrosine in growing cultures of BALB/c 3T3cells but contains little or no phosphotyrosine in cells detachedby trypsinization. The tyrosine-phosphorylated state is re-gained within minutes when the cells are replated onto fibro-nectin. Activation of FadK may be an important early step inintracellular signal transduction pathways triggered in re-sponse to cell interactions with the extracellular matrix.

    The metazoan protein-tyrosine kinases (PTKs) make up alarge segment ofthe eukaryotic protein kinase superfamily (1,2) and are known for their oncogenic potential as well as theirroles in regulating aspects of normal development (reviewedin refs. 3-5). PTKs are grouped into two broad structuralclasses on the basis of whether or not they span the plasmamembrane. Membrane-spanning PTKs include receptors forvarious peptide growth and differentiation factors such asepidermal growth factor and platelet-derived growth factor.Receptor PTK activity is stimulated upon ligand binding, andsubsequent receptor autophosphorylation followed by phos-phorylation of exogenous substrates is an initial event in thesignal transduction pathway (reviewed in refs. 5 and 6). PTKsthat do not span the plasma membrane (i.e., members of theSrc subfamily) have also been implicated in the transductionof extracellular signals that control cell growth and differen-tiation (reviewed in refs. 7-9).Given what is known about the widespread involvement of

    PTKs in regulating developmental processes, we sought toidentify and characterize PTKs, with the ultimate goal ofobtaining insight into how cells respond to environmentalcues that influence their growth and differentiation. In thisreport, we describe a non-membrane-spanning PTK identi-fied by a homology-based cDNA cloning strategy and presentevidence that its activation may be part of a signal transduc-tion pathway triggered in response to cellular interactionswith components of the extracellular matrix (ECM).t

    MATERIALS AND METHODSAmplification of PTK Catalytic-Domain cDNA Fragments

    by PCR. PTK cDNAs were amplified from adult rat testispoly(A)+ RNA by reverse transcriptase-directed PCR (10).PCR primers were designed to recognize conserved regionsin PTK catalytic domains [upstream "HRDLAA" primers,

    5'-CA(C/T)-(A/C)GN-GA(C/T)-(C/T)TN-GCN-GC-3';downstream "DVWS(FY)G" primers, 5' -CC-(A/G)(A/T)A-N(C/G)(A/T)-CCA-NAC-(A/G)TC-3'; where N = (A/C/G/T)]. The thermocycling parameters used were as follows:annealing, 2 min at 500C; extension, 3 min at 720C; denatur-ation, 0.5 min at 94TC. Amplified cDNA products of =210base pairs were subcloned and nucleotide sequences weredetermined for 200 inserts picked at random.

    Isolation ofcDNA Clones Encoding Mouse FadK and North-ern Analysis of Expression. The PCR product TK3 was usedas a probe to screen (10) a mouse 8.5-day embryo cDNAlibrary (11) constructed in AgtlO. To obtain clones represen-tative of the entire -4.5-kilobase (kb) transcript, it wasnecessary to rescreen the library with probes derived fromthe 5' and 3' ends of the initial cDNA isolates. Nucleotidesequences were determined, from both complementarystrands, for four overlapping clones to obtain the compositesequence shown.RNA isolation and Northern hybridization were done as

    described (12). The blots were hybridized with a probederived from a BamHI-Acc I fragment (nucleotides 3476-4084) in the 3' untranslated region of the FadK cDNA.

    Production of Antiserum to FadK and Antibody AffinityPurification. Anti-FadK antiserum was obtained from NewZealand White rabbits immunized with a bacterially ex-pressed fusion protein consisting of the C-terminal 150 aminoacid residues ofmouse FadK, lying downstream of 16 vector-derived residues from the pT7-7 plasmid vector (13). Anti-bodies from the immune serum were affinity-purified (14)against the fusion protein blotted to Immobilon membrane(Millipore).

    Immunoprecipitation of FadK, Immune-Complex KinaseAssay, and Phospho Amino Acid Analysis. BALB/c 3T3mouse fibroblasts (from W. J. Pledger, Vanderbilt Univer-sity) were maintained in Dulbecco's modified Eagle's me-dium (DMEM) supplemented with 10%o calf serum. Cellularproteins were metabolically labeled with [35S]methionine/cysteine by incubating the cells for 16 hr at 37°C in methio-nine-free DMEM containing 5% complete DMEM, 4% calfserum, and Tran35S-label (1000 Ci/mmol; ICN; 1 Ci = 37GBq) at 100 ,Ci/ml. Phosphoproteins were labeled by incu-bating the cells for 4 hr at 37°C in phosphate-free mediumcontaining 4% calf serum and [32P]orthophosphate (9000Ci/mmol; NEN) at 1.5 mCi/ml. Cells were lysed in RIPAbuffer (50 mM Tris Cl, pH 7.4/150 mM NaCl/5 mMEDTA/1% Nonidet P-40/1% sodium deoxycholate/0.1%SDS/1% aprotinin, 50 mM NaF/0.1 mM Na3VO4) and im-munoprecipitation of FadK was achieved by mixing 2 ,u ofantiserum with 1 ml of clarified lysate, incubating on ice for1.5 hr, and then adding 50 ul of a 50% slurry of protein

    Abbreviations: ECM, extracellular matrix; PTK, protein-tyrosinekinase.*To whom reprint requests should be addressed.tIThe sequence reported in this paper has been deposited in theGenBank data base (accession no. M95408).

    8487

    The publication costs of this article were defrayed in part by page chargepayment. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. §1734 solely to indicate this fact.

    Dow

    nloa

    ded

    by g

    uest

    on

    May

    31,

    202

    1

  • Proc. Nadl. Acad. Sci. USA 89 (1992)

    A-Sepharose (Pharmacia) and incubating 1 hr at 40C on arocking platform. Immunoprecipitates were washed in RIPAbuffer, and proteins were separated by SDS/8% PAGE anddetected by fluorography (35S) or autoradiography (32p).To demonstrate kinase activity, FadK was immunoprecip-

    itated from cell lysates as described above, except that cellproteins were unlabeled and lysis was in NP-40 Buffer (50mM Tris Cl, pH 7.4/150 mM NaCl/1% Nonidet P-40/50mMNaF/100 gM Na3VO4/1% aprotinin). The immune com-plexes were washed four times in 1 ml of NP-40 buffer andonce in kinase assay buffer (20 mM Tris Cl, pH 7.4/10 mMMgCl2/2 mM MnCl2) and suspended in 30 ,ud of kinase assaybuffer containing 4 1.M ATP and 10 ,uCi of [y-32P]ATP (4500Ci/mmol; ICN). After incubation for 10 min at 30°C, thephosphoproteins were separated by SDS/8% PAGE andvisualized by autoradiography. After acid hydrolysis ofphos-phoproteins transferred to Immobilon, phospho amino acidswere separated in two dimensions on thin-layer celluloseplates (15).

    Immunofluorescence Microscopy. BALB/c 3T3 cells,grown overnight on glass coverslips coated with rat plasmafibronectin (1 /Lg/ml; Telios Pharmaceuticals, San Diego),were rinsed in phosphate-buffered saline (PBS) and fixed for5 min in methanol/acetone (1:1, vol/vol). Fixed cells werepreincubated with 3% bovine serum albumin in PBS for 30min at 37°C, then incubated with primary antibodies for 2 hrat 37°C. The cells were then washed three times for 5 min in0.5% Nonidet P-40/PBS and rinsed twice in PBS. Thesecondary antibodies were then applied for 30 min at 37°C.After washing as above, the coverslips were mounted,viewed in a microscope equipped for epifluorescence (NikonLabophot), and photographed. The primary antibodies usedwere affinity-purified anti-FadK polyclonal antibodies, anti-talin monoclonal antibody 8d4 (16) (Sigma), and anti-phosphotyrosine monoclonal antibody py72 (17) (kindly pro-vided by Bart Sefton, Salk Institute). Secondary antibodieswere fluorescein-conjugated goat anti-rabbit IgG (VectorLaboratories) and rhodamine-conjugated goat anti-mouseIgG (Chemicon).

    Analysis of FadK Phosphotyrosine Content. FadK immu-noprecipitated from unlabeled BALB/c 3T3 cells lysed inRIPA buffer was electrophoretically separated in an SDS/polyacrylamide gel and blotted to Immobilon. The membranewas preblocked for 2 hr in Tris-buffered saline (TBS)/0.2%Tween 20 and then incubated for 2 hr in TBS/0.2% Tween 20with anti-phosphotyrosine monoclonal antibody py72 at 2Zg/ml. This was followed by a 1-hr incubation .in TBS/0.2%Tween 20 with rabbit anti-mouse IgG (Organon Teknika-Cappel) at 10 ,g/ml. Finally, the blot was incubated for 1 hrin 0.2% Tween 20/0.25% gelatin with 1251-labeled protein A(low specific activity, NEN) at 0.5 ,uCi/ml. After eachincubation, the blot was washed three times for 5 min in TBS.Immunoreactive proteins on the blot were visualized byautoradiography.To investigate changes in phosphotyrosine content of

    FadK in response to plating cells on various adhesive sub-strates, BALB/c 3T3 cells were harvested by trypsinization,washed twice in PBS with soybean trypsin inhibitor (Worth-ington), at 0.5 mg/ml, suspended in serum-free DMEM, andplated (-1.5 x 106 cells per dish) on 60-mm tissue culturedishes coated with either rat plasma fibronectin (10 pg/ml)(Telios Pharmaceuticals) or poly(L-lysine) (1 mg/ml). Thedishes were incubated at 37°C and, at various times followingplating, attached cells were washed in PBS and lysed in 1 mlof RIPA buffer. Protein concentrations in clarified lysateswere determined and samples were standardized to equalconcentrations of protein prior to immunoprecipitation ofFadK. Phosphotyrosine was then detected by probing blotsof immunoprecipitated proteins with py72.

    RESULTS

    Isolation of cDNA Clones Encoding a Non-Membrane-Sp g PTK. A PCR cloning strategy (18) was used toidentify 13 different PTK catalytic-domain cDNA fragmentsamplified from rat testis RNA. One of the cDNA fragments,TK3, was particularly abundant in the PCR library (repre-senting 44 of 200 clones sequenced) and appeared to have noclose relatives among known members of the PTK family.With the TK3 product as a probe, a mouse embryo cDNAlibrary was screened and clones were isolated that, in com-posite, included the entire protein-coding sequence for amember of the PTK family (Fig. 1). The long open readingframe encodes a protein of 1052 amino acid residues withcalculated molecular mass of 119.1 kDa. The ATG encodingthe initiating methionine conforms to the consensus fortranslation initiation (19), and just upstream of this ATG arefound stop codons in all three reading fiames. A proteinkinase catalytic domain typical of the PTKs (1, 2) andincluding sequences identical to those encoded by the ratTK3 PCR fragment encompasses amino acids 422-676. Thededuced protein does not contain a hydrophobic transmem-brane domain characteristic of growth factor receptor PTKs.Nor could we detect, aside from the catalytic domain, regionshomologous to any proteins registered in the Swiss-Prot(Release 19) and Protein Identification Resource (Release 26)data bases. In particular, the deduced protein does notcontain Src-homology SH2 or SH3 regulatory domains (20) asare present in members of the Src, Abl, and Fes/Fps sub-families. On the basis ofits localization in cultured fibroblasts(see below), this member of the PTK family has beendesignated "focal adhesion kinase" (FadK).FadK Transcripts Are Widely Expressed. Northern analysis

    ofRNA isolated from a variety of rat and mouse adult tissuesshowed that FadK transcripts are widely expressed (Fig. 2).Transcripts of =4.5 kb were detected in every rat and mouseadult tissue examined. Additional transcripts were detectedin the testis. The =4.5-kb transcript has also been detected inwhole mouse embryos (6.5-14.5 days postcoitum) and in avariety of cell lines, including BALB/c 3T3 fibroblasts (datanot shown).

    Detection of FadK and Demonstration ,f PTK Activity. Ananti-FadK antiserum was raised by immunizing rabbits witha bacterially expressed fusion protein. Antibodies in theimmune serum specifically immunoprecipitated a protein of:120 kDa (equivalent to the calculated mass of FadK) from35S-labeled BALB/c 3T3 cell lysates (Fig. 3a). When immunecomplexes formed by incubating the antiserum with lysatesof unlabeled cells were assayed for protein kinase activity,the -"120-kDa protein was found to become phosphorylated(Fig. 3b), and phospho amino acid analysis revealed that thephosphorylation was on tyrosine (Fig. 3c). These resultsprovide strong evidence that FadK is, in fact, a PTK and thatit autophosphorylates in vitro.Immuno zaon of FadK. Affinity-purified anti-FadK

    antibodies were used to localize FadK in BALB/c 3T3fibroblasts by immunostaming. [The specificity of theseantibodies for the z120 kDa FadK protein was demonstratedby probing immunoblots of total cellular proteins (data notshown)]. In well-spread cells, the antibodies stained, pre-dominantly, patchy arrowhead-shaped structures (Fig. 4a)reminiscent of focal adhesions, specialized regions of theplasma membrane formed at sites where cells adhere tightlyto the substratum (reviewed in ref. 21). Talin, a knowncomponent of focal adhesions, is colocalized with FadK(compare Fig. 4 a and b). Diffuse perinuclear staining wasalso observed in cells stained with the anti-FadK antibodies.This is accounted for, at least in part, as nonspecific stainingby the secondary antibody (Fig. 4c). Additional controlsusing primary antibodies obtained when preimmune serum

    8488 Cell Biology: Hanks et al.

    Dow

    nloa

    ded

    by g

    uest

    on

    May

    31,

    202

    1

  • Cell Biology: Hanks et al. Proc. Nati. Acad. Sci. USA 89 (1992) 8489

    AGGXAAAATGATTTTAACGTTTATCTCCAATATCGCTTATATTAAAACACTTGAAG 1091 10 20 30 40MNAA A YL D P NL N HT P S S ST KT HL GT GME R S PG A ME R VL K VFATGGAGCTCTTTCTTACCCAACTTGATCACCACAAGTCGATACTAGACCACTGGGACTGCATGAACGTCCCTGTGCATGGACGATATTAAGTCT 2292

    50 60 70 80H H F E S S S E P TT W AS I I R HG D AT D V RG I I Q K I V D SH KV KH VCATCTTTTAAAGAGTATGAGCAACACCTGGCCGTATATCAGCATGAGAGCTATGATTCAGGGCACATTAGAAATAGGGACGTCAAAAGAAAGACG 3494

    90 100 110 120ACY G FR LSH L R SE EV HWL HV D MG VSS V RE KY E LAH P P EE WGCTCAGATCCTATACGGTGAGGTCCGCGAGGGCTGTTTCGGGGGGATTACCCCCCCAAGGG 469

    130 140 150 160K Y ELR I R YL P K GF LNQ F TEDK PT L NF FY Q QVK SD Y MQ0EIAAATTATGGATGTCTCAAGATCAACGTATAGTAGCAATATTTCACAAGGAATATCTCAAAAC 589

    170 180 190 200D QV D QE I AL KL G CLE I R R SY WEM R G NA LE KK S N YE VL EK DGACATGCAGATGTTAGTGTGTGAATGCACTTTGAAGGGTAGCTGGAAGCACAGATTAAAAA 709

    210 220 230 240V GL K RFF P K SL LD SV KA K T LRKL IQ QT FR Q FAN L NR E ES IGTGTTAGGTTTCTAATTCGATTTAGCAACCAGAGTACAAAATAGATTCACTATGGAAACT 829

    250 260 270 280L KF F E I L S P VY RF D KE CF K CA LG S SW I I S VE L A I G P E EG ICTAATTTAATTTTCGGAAATGCAGGGTCATTGCTGGCATGACTTTTGATGATGCCGAAGGT 949

    290 300 310 320SYL T D KG C N PT H LA D F NQV QT I QY SN S E D KD RKG M L Q LK IAGTCTAAAAAGTATCAAACACGCTACAGGAACTCGATAAATAGCAGCGAAGAGTCATAAT 1069

    330 340 350 360A GA PE P LT VT A PSL T I AE N MA DL I DG Y CRLV N GA T Q SFI IGCGTCCTACCGCGGCGACTCTACTGCAACTGCACGTGTGTCGCGTGGAGACAAATTTACT 1189

    370 380 390 400R P Q K EG E R AL P SI PK LA N SEK QG MR T HA V SV SET D D YA E IAGCCAAAAGTACGCTGCTATCAATGCACGGAAAGCTCGCCTCGCCGGCGGCGTATTCGGT 1309

    410 420 430 440I DEE D T YT P ST RD YEI Q RE RIIE LG RC I GE GQF G DV H QG VATCGATGAGGAAGACACATACACCATGCCCTCGACCAGGGATTATGAGATTCAGAGAGAAGATGAATGGCGATGGAGTATTGAAGAATAGC 1429

    450 460 470 480JY LS P EN P A LA VAI KT CK N CT SD SV RE KF L QEA LTNMR QFD HTACGGCAAATCGTTGTTGATAACTTAACGA TCGCGGGGGGATCTCAAGCTAATCTATT 1549

    490 500 510 520PP H I V K L I G V I T EN P V W I INM E L C T L G EL R S F L Q V R K Y S L 0 LCCTCCATCTGAAMGATGGATCATACAGGAACCTGCTGGTAATATGGGTTTGCAACTTGAGACTGAGTCTTTTGCAATAAGAAAACAGTTGGCC16696

    530 540 550 560JA S L I LY A Y Q L S T A L A Y L E S K R F V H R D I A A R N V L V S S N D CVGCACT'rATTTTXMZATAGTTGTCACATCCGATTGAGGCAAGATTTTACGGACTTCTCTGGATTTTGTGMTA178978

    570 580 590 600'K L G D F G L S R Y N ED S TY Y K A S KG K L P1IK WNM A P ES I N F R R F TIAAATGGGAACTTGGATAT~rGATTATGAAGAAGTATTACATAAGCTCCAAGGAAATTACTATAAAZMATGCTCAGAGCAACAATTTCGCGTTTA19090

    610 620 630 640S A SD V WNF G V C W EI L H G V K PF QGVK N ND V IG RI E NG ERI

    650 660 670 680L P M P PN C P PT L Y SL MT K CWAY D P SRR P R F TE L KA ~L S T I LTTCATMCATGCTCACTTCGCTTAGATTGGCrTACCWGCGCAGTATACAAGTA=CCCACT 2149

    690 700 710 720EE E KVQQE ER MRHE SR R QAT V SW D SGG S D EA P P KP SR P GYGAGGGGAGAGGGCAGAAGAGAAGGATAGGAGGATCCAAAGCAGGTACCTGTCTGGACTCGGAGGTCGATAAGCCCACCAACCCACAGACTGTT22696

    730 740 750 760P S P R S S E G FY P S P QH MV QT N HY QV SG Y P G S H G I P A MAG S ICCTACCCGGATCAGTAAGGT~rATCCAGCCACACACAGGTCAGACAATACTCCAGTCTCGGCACCCGGTCCCAGGAACCCGCCAGGCTGCACA23898

    770 780 790 800Y QG Q A SL L D QT EL W NH R P QEMS M W Q P SVE D SA AL DL R G MGTACCAGGTAGGATCTTTCTGACAGACGAATGTGAATCCAGCCTCGGAGTGTCATGGGCACCCGTGTGAGATTCGCAGTTTGACCTCGAGGAGG25090

    810 820 830 840QVL P P HLNMEE R LI R Q QQE MEE D QR WLE KE ER F LK P DV RL SCAGGGCTTCCCCCACCGATGAAGGCGGTAATCGACGCAGAGGAATGAAGAGACCGCGCGGCGGAGAGGAGAGCATTCTGAACCTATGTAGGCCT26292

    850 860 870 880R G S I O RE D G S F QG P T G N QH I Y Q P VG K P D PA A P P KK P P R P GCGAGCAGCTCGAAGGGAGACGGATTTTAGGGCCGATGGAACCACACTCTACAGCTGTGGGAGCCAATCCGCAGTCCACAAGAAACTCCCGCCTG27494

    890 900 910 920A PG HL SN L SS I S SP AD SY NE G VKLQP QE I SP P P TA NL DR SGCACTGGCACCTAGCACCTTCCACATCGCAGCCTCAGAAGCTCAATAGGTGTCAGCTCAGCCCAGAAACAGCCCCCCCCATWCACCTGACCGT28696

    930 940 950 960N D KVY E N VTG L VK AV I E MS S K I Q P A P P E E YV P MV K EV G LAAATGCAAGTATAGAGATGTGCAGCCTATGAAGCTGCATCAGAGTCCGCAAATCCGCCACTCTCCAAAGATACGCCCTTGGGAAGAAGTGGCCGG29898

    970 980 990 1000L R T L LA T V D ET I P AL P A ST H R E I E MA Q K L LN S D LG E L I SKCTGCGACCTACTGCCAGGTGATGGACCTTCCGCTCTCCACCACACTATCGGAGACGAGTGGACAGAGCTCTGACTCCACTAGGCAGCTATCACA31090

    1010 1020 1030 1040M KL A0Q Y V MT S L QQE Y KK Q ML TAA HA LA VD A K NLL D VI D Q

    1050AR LK ML G QT R P H*GCAAACTGAAATCTAGGCAGCACGCCAACTGGCCCTGGCATTAACGGGCTTCTGCCTTGGGGATCTCTCAGCATCCACAGAGCGGGAATAACTT33494CCTCGTAGCCGTCTCAGGCTCAATGAAGACACTAGTGAAGTCCTCT~rATAGTTCATCCTTTACAGGTTTGATTTGTATTTTCTAATATGTTAG34696AACTTGGACCAAATGTGCATTTTTGAGATGAGATTTACATAAAAGCTTTAAATAACTTGTGTCAATTGGATGTTGTTCTAAAGTGTAATCATCT35898CCATACTTAAGTGGAAAGAATGTTGAGAGGGGGGTCCCTAGACATGAGACGGTTTCCTCCTCCAGATTCTATCAGACGTGTGCATATGTAATTC37090TTATGAGAAGTGATAAAGCTTATTTGAGAATAGTGTTTCAAAAAAATTCTCCCTCCTGCTCGCCT~rCTCTGTGATATGAGCATGGGTGCGACT38292CTOTGAACGACAAAA~TGCCTTCTCATAGAATCTGGCCATTTGTACAGAGACTCCAACGCACAAGAATTCAGGCCAGCCTTTCTCATTTTATTA39494TTATAGAAAATAAAGCATGTGATCTTCAGCACTGAGCAACGACCTCATGCGCTGTTTCCAGGAGGACCCCAGGCAAAAGGATGTGTTTCTTAG40696GTCCGTTGTATCCATCATTTGTAGGTATTTGAGGCATCCTCCCTTAGTTGTGGGGGATAAAATATTTCAGAAGATATATAATTGACAGTCCCT41898

    CCTATTAAAAAGGTGGCGCCGGAAAA AAkAAk&&A&AL&*AAAA~&AA&AAKkA&AAAAA4286

    FIG. 1. Sequence of mouse FadK cDNA and deduced amino acid sequence. Numbers at right indicate nucleotide position from the 5' endof the cDNA; numbers above amino acids indicate position from the N terminus of the encoded polypeptide. Boxed amino acid residues representthe catalytic domain.

    Dow

    nloa

    ded

    by g

    uest

    on

    May

    31,

    202

    1

  • Proc. Natl. Acad. Sci. USA 89 (1992)

    tI> Z .0Iz

    uLJ 9. x*I -j mn. c, 0

    45 218S -

    9.* - 4.5

    FIG. 2. Northern hybridization analysis of FadK transcripts inmouse (Left) and rat (Right) tissues. Ep, epididymus; Te, testis; He,heart; Mu, skeletal muscle; Ki, kidney; Li, lung; Br, brain; In,intestine; Sp, spleen; Ov, ovary. Arrowheads indicate the -4.5-kbFadK transcript. Positions of 28S and 18S rRNA are shown.

    was subjected to the affinity-purification procedure also gaveonly the diffuse perinuclear staining (data not shown).Immunostaining with anti-phosphotyrosine antibodies has

    revealed that phosphotyrosine-containing proteins in non-transformed fibroblasts are concentrated in focal adhesions(22). Double-label immunostaining ofBALB/c 3T3 cells withanti-FadK and anti-phosphotyrosine antibodies showed thatFadK is strikingly colocalized in focal adhesions with phos-photyrosine (compare Fig. 4 d and e). Thus the activity ofFadK may contribute to the observed concentration of phos-photyrosine in focal adhesions.FadK Is a Phosphoprotein and Is Phosphorylated on Tyro-

    sine in Response to Plafing BALB/c 3T3 Cells onto Fibronec-tin. At least a portion of the FadK pool in growing culturesof BALB/c 3T3 cells is present in a phosphorylated state, asdemonstrated by immunoprecipitation from 32P-labeled celllysates (Fig. 5a). The presence of phosphotyrosine in FadKwas revealed by probing a blot of proteins immunoprecipi-tated from unlabeled cell lysates with anti-phosphotyrosineantibody (Fig. 5b).The focal adhesion localization of FadK led us to investi-

    gate the possibility that its tyrosine-phosphorylated state isregulated in response to interactions with components of theECM. To test this, BALB/c 3T3 cells were harvested bytrypsinization and replated in dishes coated with eitherfibronectin (upon which cells attach and become well spreadwithin 30 min) or poly(L-lysine) (upon which cells attach butdo not immediately spread). At various times after plating,attached cells were lysed, FadK was immunoprecipitated,

    a p

    (kDa) 200-

    116- _ c

    97 -

    bP 1

    200- 0

    116- -

    97- -

    66-

    c

    66-

    FIG. 3. Immunoprecipitation ofFadK and demonstration ofPTKactivity. (a) Immunoprecipitation ofFadK metabolically labeled with[35S]methionine/cysteine. Proteins were precipitated by control pre-immune serum (lane P) or by anti-FadK immune serum (lane I). (b)In vitro kinase assay ofimmune complexes formed using preimmune(P) or immune (I) serum. (c) Phospho amino acid analysis of FadKfollowing autophosphorylation in vitro. Arrowheads in a and bindicate FadK. Arrowheads in c indicate positions of markers: S,phosphoserine; T, phosphothreonine; Y, phosphotyrosine.

    and its phosphotyrosine content was determined by probingwith anti-phosphotyrosine antibody. FadK became phos-phorylated on tyrosine as an early response to plating cellsonto fibronectin (Fig. Sc). FadK immunoprecipitated fromtrypsinized cells contained little, if any, phosphotyrosine.But within S min of plating cells onto fibronectin, tyrosine-phosphorylated FadK was clearly evident. In contrast, thephosphotyrosine content of FadK immunoprecipitated fromcells attached to poly(L-lysine) remained near the low levelsfound in trypsinized cells. A control blot using anti-FadKantiserum instead of anti-phosphotyrosine antibody verifiedthat equal amounts of FadK were present in the lysates (datanot shown). The simplest interpretation ofthese results is thatFadK is activated and autophosphorylates as a consequenceof the interaction offibronectin with its cell surface receptor.

    DISCUSSIONECM proteins markedly affect the growth, migration, anddifferentiation of eukaryotic cells, and these influences areessential for many fundamental biological processes such as

    b

    FIG. 4. Immunolocalization ofFadK in BALB/c 3T3 fibroblasts.(a and d) Cells stained for FadK.(b) Same cell as shown in a,stained for talin. (c) Control show-ing staining obtained when anti-FadK primary antibodies wereomitted from the procedure. (e)Same cell as shown in d, stainedfor phosphotyrosine.

    8490 Cell Biology: Hanks et al.

    Dow

    nloa

    ded

    by g

    uest

    on

    May

    31,

    202

    1

  • Proc. Natl. Acad. Sci. USA 89 (1992) 8491

    a b

    P I

    (kDa) 200 -

    116. <

    97 -

    66 -

    C

    P I200 -

    poly I lysine f ibroriec t in

    A T 5 10 30 60 5 10 30 60

    200 -_MO MO_

    *M.116- -97 -116- m- K

    97 -

    66 -

    66 -

    FIG. 5. Analysis of FadKphosphorylation. (a) Immunopre-cipitation of FadK metabolicallylabeled with 32p (p, preimmuneserum; I, immune serum). (b) De-tection of phosphotyrosine in im-munoprecipitated FadK, using an-ti-phosphotyrosine antibody (P,preimmune serum; I, immune se-rum). (c) Analysis of FadK phos-photyrosine content 5, 10, 30, and60 min after plating cells onto fi-bronectin or poly(L-lysine). LaneA, lysate from cells attached andgrowing under standard cultureconditions; lane T, lysate fromcells harvested by trypsinization.Arrowheads indicate FadK.

    embryogenesis, wound healing, and malignant transforma-tion (reviewed in refs. 23 and 24). Clearly, intracellularsignaling processes must be activated at sites of cell-ECMcontact. How are these signals mediated? Evidence pointingto a role for PTKs has accumulated. Recent studies haverevealed rapid and dramatic increases in phosphotyrosinecontent of an 120-kDa protein after plating mouse NIH 3T3fibroblasts on fibronectin (25), and of 115- to 130 kDa proteinsafter incubating human KB epithelial cells with antibodies tothe P13 integrin component ofthe fibronectin receptor (26). Onthe basis of the results presented here, we suggest that FadKis a major component of the phosphotyrosine-containingproteins described in these earlier studies. It will be ofinterest to measure changes in FadK phosphotyrosine con-tent following cell attachment to other ECM proteins thatinteract with distinct integrin receptors.Our observations suggest a model for fibronectin-induced

    intracellular signaling initiated by the aggregation of integrinreceptors at focal adhesions, with the coincident autophos-phorylation of associated FadK molecules. Subsequently,FadK may phosphorylate exogenous substrates, setting off acascade of events that bring about alterations in cellularproperties. This would be analogous to the proposed mech-anisms for growth factor signal transduction across theplasma membrane involving the aggregation and intermolec-ular autophosphorylation of receptor PTKs (5, 6) and for theactivation of the lymphocytic Src-subfamily PTKs throughtheir interactions with transmembrane components of anti-gen receptor complexes (7-9). How might FadK transmit asignal within the cell? One pathway might involve the asso-ciation with, and phosphorylation of, proteins that containSH2 domains, which are known to interact with phosphoty-rosine (20). In this context, the focal adhesion protein tensin,isolated and characterized on the basis of its ability to bindactin filaments (27), has been reported to contain an SH2domain (28). The association between tensin and FadKphosphotyrosine may be an important step in the anchorageof actin filaments to the submembraneous cytoskeleton.As this report was being prepared, we learned that a PTK

    similar in structure to FadK has very recently been identifiedas a cDNA clone isolated from a chicken embryo library (29).This chicken PTK, designated pp125FAK, is highly similarthroughout its length to mouse FadK, and their catalyticdomains share 98% identical amino acid residues. Likemouse FadK, chicken pp125FAK was shown to localize tofocal adhesions (29). Thus, these two PTKs appear to befunctional homologs.

    We thank Tom Daniel, Ron Gates, and Kathy Gould for helpfuldiscussions, Brigid Hogan for providing the mouse embryo cDNA

    library, Stan Tabor for providing the pT7-7 expression vector, andTom Parsons for providing a copy of a manuscript prior to publica-tion. This work was supported by National Institutes of HealthGrants GM38793 and HD28375.

    1. Hanks, S. K., Quinn, A. M. & Hunter, T. (1988) Science 241,42-52.

    2. Hanks, S. K. (1991) Curr. Opin. Struct. Biol. 1, 369-383.3. Hunter, T. & Cooper, J. A. (1985) Annu. Rev. Biochem. 54,

    897-930.4. Pawson, T. & Bernstein, A. (1990) Trends Genet. 6, 350-356.5. Ullrich, A. & Schlessinger, J. (1991) Cell 61, 203-212.6. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B.,

    Graziani, A., Kapeller, R. & Soltoff, S. (1991) Cell 64, 281-302.7. Sefton, B. M. (1991) Oncogene 6, 683-686.8. Klausner, R. D. & Samuelson, L. E. (1991) Cell 64, 875-878.9. Bolen, J. B. (1991) Cell Growth Differ. 2, 409-414.

    10. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) MolecularCloning:A Laboratory Manual (Cold Spring Harbor Lab., ColdSpring Harbor, NY), 2nd Ed.

    11. Fahrner, K., Hogan, B. L. M. & Flavell, R. A. (1987) EMBOJ. 6, 1265-1271.

    12. Hanks, S. K. (1989) Mol. Endocrinol. 3, 110-116.13. Tabor, S. (1990) in Current Protocols in Molecular Biology,

    eds. Ausubel, F. A., Brent, R., Kingston, R. E., Moore, D. D.,Seidman, J. G., Smith, J. A. & Struhl, K. (Greene/Wiley-Interscience, New York), pp. 16.2.1-16.2.11.

    14. Olmsted, J. B. (1981) J. Biol. Chem. 256, 11955-11957.15. Boyle, W. J., van der Geer, P. & Hunter, T. (1991) Methods

    Enzymol. 201, 110-149.16. Otey, C., Griffiths, W. & Burridge, K. (1990) Hybridoma 9,

    57-62.17. Glenney, J. R., Zokas, L. & Kamps, M. P. (1988) J. Immunol.

    Methods 109, 277-285.18. Wilks, A. F. (1989) Proc. Natl. Acad. Sci. USA 86, 1603-1607.19. Kozak, M. (1991) J. Cell Biol. 115, 887-903.20. Koch, C. A., Anderson, D., Moran, M. F., Ellis, C. & Pawson,

    T. (1991) Science 252, 668-674.21. Burridge, K., Fath, K., Kelly, T., Nuckolls, G. & Turner, C.

    (1988) Annu. Rev. Cell Biol. 4, 487-525.22. Maher, P. A., Pasquale, E. B., Wang, J. Y. J. & Singer, S. J.

    (1985) Proc. Natl. Acad. Sci. USA 82, 6576-6580.23. Hynes, R. 0. & Lander, A. D. (1992) Cell 68, 303-322.24. Ruoslahti, E. (1988) Annu. Rev. Biochem. 57, 375-413.25. Guan, J.-L., Trevithick, J. E. & Hynes, R. 0. (1991) Cell

    Regul. 2, 951-964.26. Kornberg, L. J., Earp, H. S., Turner, C. E., Prockop, C. &

    Juliano, R. L. (1991) Proc. Natl. Acad. Sci. USA 88, 8392-83%.

    27. Wilkins, J. A., Risinger, M. A. & Lin, S. (1986) J. Cell Biol.103, 1483-1494.

    28. Davis, S., Lu, M. L., Lo, S. H., Lin, S., Butler, J. A.,Drucker, B. J., Roberts, T. M., An, Q. & Chen, L. B. (1991)Science 252, 712-715.

    29. Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R.,Reynolds, A. B. & Parsons, J. T. (1992) Proc. Natl. Acad. Sci.USA 89, 5192-51%.

    Cell Biology: Hanks et al.

    Dow

    nloa

    ded

    by g

    uest

    on

    May

    31,

    202

    1